Who owns Janux Therapeutics, Inc.?

In the current sources, Janux Therapeutics, Inc. is connected to RA Capital Healthcare Fund LP, Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., Shah Rajeev M., Shah Rajeev M. and 10 more. Trace the full chain to the ultimate beneficial owner in the WhiteIntel ownership graph.

What is Janux Therapeutics, Inc.'s risk level?

WhiteIntel flags Janux Therapeutics, Inc. as medium risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Janux Therapeutics, Inc. appear across sources?

Janux Therapeutics, Inc. is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

SnitchScore · reading…

evidence coverage · reading…

Coverage — measured

Ownership hops held: 61

An absent edge means not yet observed — never does not exist.

Legal entityMedium

Janux Therapeutics, Inc.

Name: Janux Therapeutics, Inc. — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Janux Therapeutics, Inc., Company, US

Janux Therapeutics, Inc. — US company (sec:0001817713). UBO chain traced 61 hops, 15 owners. Every claim linked to its source.

SEC 0001817713CompanyUS

Ownership graph Export .md

JSON / MCPsample

The finding

Ownership resolves 61 hops deep toward the ultimate beneficial owner.

Investigative lead by resolved identity, not a legal determination.

/01

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers

Janux Therapeutics, Inc.
- RA Capital Healthcare Fund LP· 10% owner· via SEC EDGAR (Form 3/4/5)
- Kolchinsky Peter· 10% owner· via SEC EDGAR (Form 3/4/5)
- RA CAPITAL MANAGEMENT, L.P.· 10% owner· via SEC EDGAR (Form 3/4/5)
- Shah Rajeev M.· 10% owner· via SEC EDGAR (Form 3/4/5)
- LICHTER JAY· tenpercentowner· via SEC EDGAR
- AVALON BIOVENTURES SPV I, L.P.· tenpercentowner· via SEC EDGAR
- AVALON BIOVENTURES I, LP· tenpercentowner· via SEC EDGAR
- AVALON VENTURES XI, L.P.· tenpercentowner· via SEC EDGAR
- REARDON TIGHE· tenpercentowner· via SEC EDGAR
- BREGUA CORP· tenpercentowner· via SEC EDGAR
- Thompson Peter A.· tenpercentowner· via SEC EDGAR

Holdings / subsidiaries

None in current sources.

Walk the full UBO chain

61 hops lockedSTANDARD

61-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.

Unlock Standard Dossier€39

/02

People & control

20 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
BARRETT RONALD W
Also holds roles at 3 other companies
- XENOPORT INCdirector
- XENOPORT INCofficer
- CONCERT PHARMACEUTICALS INCdirector
●
CAPPS VICKIE L
Also holds roles at 9 other companies
- Orthofix Medical Inc.director
- DJ ORTHOPEDICS INCofficer
- AMEDISYS INCdirector

18 additional parties & networkSTANDARD

●
DOBMEIER ERIC
Also holds roles at 9 other companies
- SEAGEN INC.officer
- Structure Therapeutics Inc.director
- AEROVATE THERAPEUTICS, INC.director
●
GUJRATHI SHEILA
Also holds roles at 6 other companies
- Ventyx Biosciences, Inc.director
- TP THERAPEUTICS, INCdirector
- Gossamer Bio, Inc.officer
●
HERNDAY NATASHA
Also holds roles at 3 other companies
- XOMA Royalty Corpdirector
- ALPINE IMMUNE SCIENCES, INC.director
- PDL BIOPHARMA, INC.director
●
Kolchinsky Peter
Also holds roles at 130 other companies
- Mineralys Therapeutics, Inc.director
- Solid Biosciences Inc.10% owner
- Sionna Therapeutics, Inc.10% owner
●
Kung Winston
Also holds roles at 4 other companies
- ArriVent BioPharma, Inc.officer
- Corbus Pharmaceuticals Holdings, Inc.director
- PMV Pharmaceuticals, Inc.officer
●
LICHTER JAY
Also holds roles at 8 other companies
- OTONOMY, INC.director
- SYNTHORX, INC.director
- SYNTHORX, INC.tenpercentowner
●
MCNULTY ALANA B.
Also holds roles at 2 other companies
- GRAF ACQUISITION CORP. IVdirector
- EFFECTOR THERAPEUTICS, INC.officer
●
ORBIMED ADVISORS LLC
Also holds roles at 172 other companies
- Disc Medicine, Inc.director
- MBX Biosciences, Inc.10% owner
- Sionna Therapeutics, Inc.director
●
OrbiMed Capital GP VII LLC
Also holds roles at 30 other companies
- MBX Biosciences, Inc.10% owner
- Passage BIO, Inc.10% owner
- Enliven Therapeutics, Inc.tenpercentowner
●
OrbiMed Capital GP VIII LLC
Also holds roles at 15 other companies
- Disc Medicine, Inc.director
- Sionna Therapeutics, Inc.director
- Traws Pharma, Inc.10% owner
●
OrbiMed Genesis GP LLC
Also holds roles at 40 other companies
- Disc Medicine, Inc.director
- MBX Biosciences, Inc.10% owner
- Q32 Bio Inc.director
●
RA Capital Healthcare Fund LP
Also holds roles at 118 other companies
- Mineralys Therapeutics, Inc.director
- Solid Biosciences Inc.10% owner
- Sionna Therapeutics, Inc.10% owner
●
RA CAPITAL MANAGEMENT, L.P.
Also holds roles at 125 other companies
- Mineralys Therapeutics, Inc.director
- Solid Biosciences Inc.10% owner
- Sionna Therapeutics, Inc.10% owner
●
RA Capital Nexus Fund II, L.P.
Also holds roles at 22 other companies
- Acrivon Therapeutics, Inc.director
- PepGen Inc.director
- HEMAB THERAPEUTICS HOLDINGS, INC.director
●
REARDON TIGHE
Also holds roles at 1 other company
- SYNTHORX, INC.officer
●
Shah Rajeev M.
Also holds roles at 102 other companies
- Mineralys Therapeutics, Inc.director
- Solid Biosciences Inc.10% owner
- Sionna Therapeutics, Inc.10% owner
●
SIMSON JAKE
Also holds roles at 5 other companies
- FOG PHARMACEUTICALS, INC.director
- Septerna, Inc.director
- Bicara Therapeutics Inc.director
●
Thompson Peter A.
Also holds roles at 27 other companies
- Sionna Therapeutics, Inc.director
- ARS Pharmaceuticals, Inc.director
- Edgewise Therapeutics, Inc.tenpercentowner

●
DOBMEIER ERIC
Also holds roles at 9 other companies
- SEAGEN INC.officer
- Structure Therapeutics Inc.director
- AEROVATE THERAPEUTICS, INC.director
●
GUJRATHI SHEILA
Also holds roles at 6 other companies
- Ventyx Biosciences, Inc.director
- TP THERAPEUTICS, INCdirector
- Gossamer Bio, Inc.officer
●
HERNDAY NATASHA
Also holds roles at 3 other companies
- XOMA Royalty Corpdirector
- ALPINE IMMUNE SCIENCES, INC.director
- PDL BIOPHARMA, INC.director
●
Kolchinsky Peter
Also holds roles at 130 other companies
- Mineralys Therapeutics, Inc.director
- Solid Biosciences Inc.10% owner
- Sionna Therapeutics, Inc.10% owner
●
Kung Winston
Also holds roles at 4 other companies
- ArriVent BioPharma, Inc.officer
- Corbus Pharmaceuticals Holdings, Inc.director
- PMV Pharmaceuticals, Inc.officer
●
LICHTER JAY
Also holds roles at 8 other companies
- OTONOMY, INC.director
- SYNTHORX, INC.director
- SYNTHORX, INC.tenpercentowner
●
MCNULTY ALANA B.
Also holds roles at 2 other companies
- GRAF ACQUISITION CORP. IVdirector
- EFFECTOR THERAPEUTICS, INC.officer
●
ORBIMED ADVISORS LLC
Also holds roles at 172 other companies
- Disc Medicine, Inc.director
- MBX Biosciences, Inc.10% owner
- Sionna Therapeutics, Inc.director
●
OrbiMed Capital GP VII LLC
Also holds roles at 30 other companies
- MBX Biosciences, Inc.10% owner
- Passage BIO, Inc.10% owner
- Enliven Therapeutics, Inc.tenpercentowner
●
OrbiMed Capital GP VIII LLC
Also holds roles at 15 other companies
- Disc Medicine, Inc.director
- Sionna Therapeutics, Inc.director
- Traws Pharma, Inc.10% owner
●
OrbiMed Genesis GP LLC
Also holds roles at 40 other companies
- Disc Medicine, Inc.director
- MBX Biosciences, Inc.10% owner
- Q32 Bio Inc.director
●
RA Capital Healthcare Fund LP
Also holds roles at 118 other companies
- Mineralys Therapeutics, Inc.director
- Solid Biosciences Inc.10% owner
- Sionna Therapeutics, Inc.10% owner
●
RA CAPITAL MANAGEMENT, L.P.
Also holds roles at 125 other companies
- Mineralys Therapeutics, Inc.director
- Solid Biosciences Inc.10% owner
- Sionna Therapeutics, Inc.10% owner
●
RA Capital Nexus Fund II, L.P.
Also holds roles at 22 other companies
- Acrivon Therapeutics, Inc.director
- PepGen Inc.director
- HEMAB THERAPEUTICS HOLDINGS, INC.director
●
REARDON TIGHE
Also holds roles at 1 other company
- SYNTHORX, INC.officer
●
Shah Rajeev M.
Also holds roles at 102 other companies
- Mineralys Therapeutics, Inc.director
- Solid Biosciences Inc.10% owner
- Sionna Therapeutics, Inc.10% owner
●
SIMSON JAKE
Also holds roles at 5 other companies
- FOG PHARMACEUTICALS, INC.director
- Septerna, Inc.director
- Bicara Therapeutics Inc.director
●
Thompson Peter A.
Also holds roles at 27 other companies
- Sionna Therapeutics, Inc.director
- ARS Pharmaceuticals, Inc.director
- Edgewise Therapeutics, Inc.tenpercentowner

Unlock all 20 parties, full beneficial ownership chains & directorship networks.

Unlock Standard Dossier€39

20 parties · 0 current. Ceased and resigned records are retained as history.

Standard Dossier€39

The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.

Everything we hold on Janux Therapeutics, Inc., resolved and sourced — yours to keep, no subscription.

INCLUDED WHEN YOU UNLOCK

UBO trace
Branded PDF + un-redacted JSON · every claim linked to its source
Re-download for 90 days

UBO trace

Guest checkout · email only · re-download 90 days. Or subscribe from €149.

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, address & registry profile
Sanctions & watchlist detail
Direct connections (1 hop)
Community notes

YOURS AFTER YOU UNLOCK · PAID

2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.

Full ownership trace to the UBOSTANDARD
Full export (PDF + un-redacted JSON) & change alertsPREMIUM

/03

Common questions

Who owns Janux Therapeutics, Inc.?: In the current sources, Janux Therapeutics, Inc. is connected to RA Capital Healthcare Fund LP, Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., Shah Rajeev M., Shah Rajeev M. and 10 more. Trace the full chain to the ultimate beneficial owner in the WhiteIntel ownership graph.
What is Janux Therapeutics, Inc.'s risk level?: WhiteIntel flags Janux Therapeutics, Inc. as medium risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does Janux Therapeutics, Inc. appear across sources?: Janux Therapeutics, Inc. is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Janux Therapeutics, Inc.. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…